Kiromic Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Kiromic Biopharma, Inc. has filed 252 SEC EDGAR filings since 15 Nov 2019

SEC filing history

Showing 151-175 of 252 matching filings.

Per page
25
Current page
7
DEF 14A File 001-39619

DEF 14A

Filing date
29 Apr 2022
Reporting date
22 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-39619

NT 10-K

Filing date
01 Apr 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-92643

KIROMIC BIOPHARMA, INC.

Filing date
13 Jan 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 001-39619

NT 10-Q

Filing date
16 Nov 2021
Reporting date
30 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
14 Oct 2021
Reporting date
30 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
10 Sep 2021
Reporting date
09 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39619

8-K

Filing date
04 Aug 2021
Reporting date
29 Jul 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .